This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
BioMarin, multiple quarters into its portfolio refinement, is inking a small acq...
Plus, news about vTv Therapeutics, Dynavax, Aura Biosciences and ArkBio: FDA...
Novo Nordisk CEO Lars Fruergaard Jørgensen will step down, the company announced...
The last time a biotech went public on a US stock exchange, people were buying f...
→ Leo Pharma is doing an extensive revamp of its leadership team as it splits pr...
NEW YORK — Calley Means, a special White House employee and top advisor to HHS S...
A Delaware jury on Thursday said Regeneron should get more than $400 million in ...
Eisai executives said on Thursday that Leqembi sales and shipments in the US are...
Vinay Prasad may have just started as the new director of the FDA's biologics ce...
Eli Lilly is building out its gene therapy pipeline for hearing loss through a n...
PHILADELPHIA — Soon after Kyle Patrick Muldoon, Jr. was born in August 2024, his...
The FDA’s drug promotion office is calling out Australia's Mayne Pharma for maki...
NEW YORK — Bristol Myers Squibb CEO Chris Boerner said America’s role as the glo...
Pathos AI, seeking to upend cancer drug development with artificial intelligence...